Jim Ryszewski, Mha
About Jim Ryszewski, Mha
Jim Ryszewski is the Director of Physician Networks and Strategic Accounts at Mirati Therapeutics, where he has worked since 2021. He has a diverse background in the pharmaceutical industry, having held various leadership roles at companies such as Puma Biotechnology and Lexicon Pharmaceuticals.
Work at Mirati Therapeutics
Jim Ryszewski serves as the Director of Physician Networks and Strategic Accounts at Mirati Therapeutics. He has held this position since 2021, contributing to the company's strategic initiatives in Detroit, Michigan. His role involves managing relationships with healthcare providers and overseeing strategic account operations to enhance the company's market presence.
Previous Experience at Puma Biotechnology, Inc.
Before joining Mirati Therapeutics, Jim Ryszewski worked at Puma Biotechnology, Inc. He served as Associate Director of Strategic Accounts from 2020 to 2021, where he played a key role in developing and managing strategic partnerships. Prior to that, he was a Senior Regional Manager at the same company from 2017 to 2020, focusing on regional business development in South San Francisco, California.
Background in Pharmaceuticals
Jim Ryszewski has extensive experience in the pharmaceutical industry. He worked at Lexicon Pharmaceuticals, Inc. as a Regional Business Leader from 2016 to 2017, covering the Great Lakes and Midwest regions. Additionally, he served as Regional Business Director at Onyx Pharmaceuticals, Inc., an Amgen subsidiary, from 2012 to 2016, where he managed business operations in the Great Lakes area.
Education and Expertise
Jim Ryszewski holds a Bachelor of Arts degree from the University of Dayton and a Master of Health Administration (MHA) from Xavier University. His educational background supports his expertise in healthcare management and strategic account development within the pharmaceutical sector.
Early Education
Jim Ryszewski completed his early education at Grosse Pointe South. This foundational education contributed to his professional development and career trajectory in the healthcare and pharmaceutical industries.